Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term Follow-Up for the Pathway CH-1 Trial: Sphenopalatine Ganglion Stimulation for the Acute Treatment of Cluster Headache

NCT01616511 is registered in ClinicalTrials.gov with Autonomic Technologies, Inc. as lead sponsor.

NCT NCT01616511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01616511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term Follow-Up for the Pathway CH-1 Trial: Sphenopalatine Ganglion Stimulation for the Acute Treatment of Cluster Headache
Lead sponsor
Autonomic Technologies, Inc.
Phase
Observational
Overall status
Completed
Start date
June 30, 2012
Completion date
June 30, 2016
Enrollment
33 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chronic cluster headache